management team   company  news   our people   awards  our people  management team   scientific advisors   board of directors  management team erich mohr phd rpsychchairman  chief executive officerfounder of medgenesis therapeutix inc erich mohr phd rpsych is the chairman and ceo of medgenesis therapeutix inc which he founded in  dr mohr a professor of medicine and psychology at the university of ottawa until  has over  years of experience in experimental therapeutics of cns disorders he is credited with over  publications books book chapters and abstracts and has edited the handbook of clinical trials the neurobehavioral approach dr mohr has chaired andor served on several regulatory advisory panels for the approval of new products for the treatment of neurodegenerative disease and is the former chairman and chief executive officer of cromedica global inc which merged with pra international in  to form one of the top  contract research organizations in the world and the cofounder of several biotechnology companies his most recent position was with pra international where he served as chief scientific officer over the course of his career dr mohr has overseen andor participated in dozens of clinical development programs resulting in a number of approved drugs h christian fibiger phdchief scientific officer h christian fibiger phd received his bsc in chemistry and psychology from the university of victoria in  and his phd in psychopharmacology from princeton university in  dr fibiger was formerly senior vice president and chief scientific officer for biovail laboratories international  from  until  he was vice president and global head of neuroscience at amgen in this position he was responsible for amgens worldwide neuroscience discovery efforts ranging from early exploratory research through clinical candidate selection before joining amgen in  dr fibiger served as vice president of neuroscience discovery research and clinical investigation and lrl europe at eli lilly and company prior to moving to lilly in  dr fibiger was professor and head of the division of neurological sciences and chair of the university graduate program in neuroscience at the university of british columbia in vancouver he has made numerous contributions to neuroscience research and during his academic career was among the top  most cited scientists in neuroscience he has received many honors for his research contributions including the clark institute prize in psychiatry the heinz lehmann award of the canadian college of neuropsychopharmacology the killam research prize the gold medal in health sciences from the science council of british columbia and the tanenbaum distinguished scientist award in schizophrenia research he is a fellow of the american college of neuropsychopharmacology acnp dr fibiger has served on the editorial boards of leading neuroscience journals and has been coeditor of neuropsychopharmacology the official publication of the acnp he is currently a board member of a number of neuroscience focussed biotechnology companies chief scientific officer hls therapeutics inc and assistant dean research faculty of medicine university of british columbia lara longpre msc mbachief operating officer ms longpre rejoined medgenesis in october  as chief operating officer she brings to medgenesis more than  years of experience developing innovative and complex therapies most recently at jennerex biotherapeutics where as chief operating officer as coo she was responsible for program management for the lead product alliance management across  international collaboration partners clinical operations for over  clinical trials technical operations regulatory affairs and quality assurance prior to jennerex ms longpre was senior vicepresident clinical  corporate affairs at medgenesis where she was responsible for business operations including the intellectual property portfolio corporate files and clinical development plans and budgets ms longpre continued to serve as a consultant to medgenesis during her tenure at jennerex ms longpre previously held several senior positions with pra internationalcromedica including operations regulatory affairs and proposals  contracts she holds a ba in biology from cornell university an msc from harvard medical school and an mba from queens university matthias luz mdchief medical officer dr luz is a boardcertified anesthesiologist and intensive care physician with an extensive background in epidemiology clinical trial methodology and global regulatory affairs in addition to  years of clinical experience dr luz has  years of global product development experience in the biopharmaceutical and clinical research industry before joining medgenesis in  dr luz was the vice president and head global product development services for pra international in this capacity dr luz led an accomplished team of senior physicianscientists and drug development experts involved in the design and implementation of high quality development programs from preind to phase iii and submission during a previous tenure at behringwerkehoechst marion rousselaventis dr luz led the team that brought refludan� the first therapeutic for heparininduced thrombocytopenia to market worldwide dr luz also held other senior positions at knollabbott and cardion     � medgenesis therapeutix inc   page not found  relationship science news home advertising board and executive moves energy health care hedge funds m  a private equity technology page not found oops looks like you followed a bad link click here to start over are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ erich mohr  medgenesis therapeutix inc  zoominfocom delmar pharmaceuticals appoints saiid zarrabian to the board of directors and names dr erich mohr delmar pharmaceuticals appoints saiid zarrabian to the board of directors and names dr erich mohr as chairman company adopts omnibus equity incentive plan and policy to better align with shareholder values and facilitate growth news provided by delmar pharmaceuticals inc jul    et share this article vancouver british columbia and menlo park calif july   prnewswire  delmar pharmaceuticals nasdaq dmpi delmar and the company a biopharmaceutical company developing new cancer therapies today announced that mr saiid zarrabian has joined the companys board of directors and dr erich mohr has been elected to serve as its chairman  this board strengthening initiative seeks to establish a more robust and independent board and to enable jeffery bacha who has been both the companys ceo and chairman since inception in  to focus on his growing operational role as ceo with the planned expansion of clinical trials for val across different oncology indications and stages of disease delmar has reached a point in its corporate and clinical maturation where we are excited to have access to saiids operational expertise and experience guiding multiple companies in their transition from scientific development to commercial success commented jeffrey bacha delmars president  chief executive officer furthermore i am very pleased that erich has agreed to take on the role of chairman as his executive leadership clinical development and company building experience will greatly benefit delmar as we continue the next phase of our growth  in the near term this includes the launch of the val star gbm trial – our pivotal phase  clinical trial in refractory gbm – as well as the expansion of our clinical portfolio into newly diagnosed gbm and other indications added mr bacha saiid zarrabian comes to delmar with over  years of senior executive or board member experience for multiple public and private companies culminating in the creation of more than three billion dollars of shareholder value mr zarrabian is currently serving as an advisor to redline capital partners sa a luxemburg based investment firm mr zarrabian has previously served as chairman and member of the board of la jolla pharmaceutical company during the companys transition from an otc listed company to a successful nasdaq listed company mr zarrabian previously served as president of the protein production division of intrexon corporation a synthetic biology company as ceo  member of the board of cyntellect inc a stem cell processing and visualization instrumentation company until its sale in  as president and coo of senomyx inc a company focused on discovery and commercialization of new flavor ingredients as coo of pharmacopeia inc a former publiclytraded provider of combinatorial chemistry discovery services and compounds where he also served as president  coo of its msi division in addition mr zarrabian has served on numerous private and public company boards including at immune therapeutics inc exemplar pharma llc ambit biosciences corporation emolecules inc and penwest pharmaceuticals co his other experience includes coo at molecular simulations coo of symbolics inc and as rd director at computervision inc dr erich mohr phd r psych has served as a director of delmar since march   and has nearly two decades of biotechnology experience in executive leadership roles as cofounder chief scientific officer chief executive officer and board member leading to well over a billion dollars of value creation dr mohr has overseen and participated in dozens of clinical development programs and regulatory advisory panels he is currently chairman chief executive officer and founder of medgenesis therapeutix inc a privatelyheld biopharmaceutical company committed to developing and commercializing innovative therapeutics to provide lifeenhancing treatments to patients with serious neurologic diseases formerly he was chairman and chief executive officer of cromedica global inc which merged with pra international in  to form one of the major contract research organizations in the world in addition to his industry experience dr mohr has over  years of academic experience in experimental therapeutics of cns disorders including eight years at the university of ottawa ultimately as a professor of medicine neurology and psychology dr mohr is the author of over  publications books book chapters and abstracts he is the former chair of the board of governors of the university of victoria he earned his masters of science and phd in neuropsychology at the university of victoria british columbia and his bachelors of arts in psychology and dual bachelors of science in chemistry and biology from the university of the pacific in stockton california additionally to facilitate delmars growth and align interests with shareholders the company has adopted an omnibus equity incentive plan which will be presented to shareholders for approval at the companys annual general meeting  the company also announced that it plans to review its corporate policies and consider additional steps to align interests with shareholders and that it has adopted a policy to provide for a shareholder advisory vote on the companys compensation philosophy every two years at its annual general meeting  under the omnibus equity incentive plan  common shares are reserved for issuance of which  represent options previously granted or reserved under the delmar pharmaceuticals bc ltd  amended and restated stock option plan securities issued under the omnibus equity incentive plan will not vest or become exercisable until the plan is approved by shareholders about delmar pharmaceuticals inc delmar pharmaceuticals inc is developing cancer therapies in indications where patients are failing or have become intolerable to modern targeted or biologic treatments the companys pipeline is based around val a firstinclass smallmolecule chemotherapeutic with a novel mechanism of action that has demonstrated clinical activity against a range of cancers including glioblastoma multiforme gbm ovarian and other solid tumors eg nsclc bladder cancer head  neck in us clinical trials sponsored by the national cancer institute nci val has received an orphan drug designation in europe for the treatment of malignant gliomas and the us fda office of orphan products has granted an orphan designation for the treatment of glioma medulloblastoma and ovarian cancer in  the company plans to file an ind for val in ovarian cancer enter into a pivotal randomized multicenter phase  clinical trial for the treatment of bevacizumabfailed gbm a phase ii trial with md anderson cancer center in first recurrence gbm patients prior to bevacizumab therapy and into a separate international phase  trial for newly diagnosed mgmtunmethylated gbm connect with the company on twitter linkedin facebook and google safe harbor statement any statements contained in this press release that do not describe historical facts may constitute forwardlooking statements as that term is defined in the private securities litigation reform act of  any forwardlooking statements contained herein are based on current expectations but are subject to a number of risks and uncertainties the factors that could cause actual future results to differ materially from current expectations include but are not limited to risks and uncertainties relating to the companys ability to develop market and sell products based on its technology the expected benefits and efficacy of the companys products and technology the availability of substantial additional funding for the company to continue its operations and to conduct research and development clinical studies and future product commercialization and the companys business research product development regulatory approval marketing and distribution plans and strategies these and other factors are identified and described in more detail in our filings with the sec including our current reports on form k   view original content with multimediahttpwwwprnewswirecomnewsreleasesdelmarpharmaceuticalsappointssaiidzarrabiantotheboardofdirectorsandnamesdrerichmohraschairmanhtml source delmar pharmaceuticals inc related links httpdelmarpharmacom jul    et preview delmar pharmaceuticals announces completion of first site initiation visit for star pivotal phase  clinical trial of val in refractory gbm jun    et preview delmar pharmaceuticals joins national brain tumor societys research roundtable my news release contains wide tables view fullscreen also from this source jul    et delmar pharmaceuticals announces completion of first site jun    et delmar pharmaceuticals joins national brain tumor societys explore more news releases in similar topics health care  hospitals medical pharmaceuticals personnel announcements you just read delmar pharmaceuticals appoints saiid zarrabian to the board of directors and names dr erich mohr as chairman news provided by delmar pharmaceuticals inc jul    et share this article looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search form  delmar pharmaceuticals for jul  filed by mohr erich close x set up related email alerts – free categories entities stocks sign up sec filings dmpi email address login  home  email alerts  my headlines  portfolio upgrade to streetinsider premium  free trial home menu join si premium ratings ma insider eps insider dividends ipo insider hedge funds premium letters submit release join si premium full feed view headline view si premium squawk box alerts custom headlines upgrade to si premium license calendars dividend calendar earnings calendar event driven fda calendar investor conferences ipo calendar merger arb ratings calendar stock split calendar ratings analyst comments hot analyst comments analyst eps change analyst eps view analyst pt change credit ratings downgrade news hot downgrades new coverage news hot new coverage upgrade news hot upgrades more ma insider merger news hot ma news private equity rumors spinoffs merger arbitrage event driven  top ma deals top  takeover targets more eps insider earnings calendar earnings news hot earnings guidance hot guidance conference calls earnings history search more dividends dividend calendar dividend news hot dividends dividend hike special dividends stock buybacks hot stock buybacks stock splits more ipo insider ipo news hot ipos equity offerings recent ipos upcoming ipos  top ipos more hedge funds d f g hedge funds news hot insider trades insider trades more premium letters new  dividend insider elite pulse picks ratings insider elite stealth growth insider submit release quick links  goldman sachs conviction buy list carl icahn news warren buffett news ackman news follow streetinsider sec filings form  delmar pharmaceuticals for jul  filed by mohr erich article stock quotes  comments  july    pm edt tweet share email  shares news and research before you hear about it on cnbc and others claim your week free trial to streetinsider premium here form  united states securities and exchange commissionwashington dc statement of changes in beneficial ownershipfiled pursuant to section a of the securities exchange act of or section h of the investment company act of  omb approval omb number  expires december   estimated average burden hours per response     check this box if no longer subject to section  form  or form  obligations may continue see instruction b  name and address of reporting person mohr erich last first middle suite  west broadway street vancouver a vz k city state zip  issuer name and ticker or trading symbol delmar pharmaceuticals inc  dmpi   relationship of reporting persons to issuer check all applicable x director  owner officer give title below other specify below  date of earliest transaction monthdayyear  if amendment date of original filed monthdayyear  individual or jointgroup filing check applicable line x form filed by one reporting person form filed by more than one reporting person table i  nonderivative securities acquired disposed of or beneficially owned  title of security instr   transaction date monthdayyear a deemed execution date if any monthdayyear  transaction code instr   securities acquired a or disposed of d instr   and   amount of securities beneficially owned following reported transactions instr  and   ownership form direct d or indirect i instr   nature of indirect beneficial ownership instr  code v amount a or d price table ii  derivative securities acquired disposed of or beneficially ownedeg puts calls warrants options convertible securities  title of derivative security instr   conversion or exercise price of derivative security  transaction date monthdayyear a deemed execution date if any monthdayyear  transaction code instr   number of derivative securities acquired a or disposed of d instr   and   date exercisable and expiration date monthdayyear  title and amount of securities underlying derivative security instr  and   price of derivative security instr   number of derivative securities beneficially owned following reported transactions instr   ownership form direct d or indirect i instr   nature of indirect beneficial ownership instr  code v a d date exercisable expiration date title amount or number of shares options right to buy      a         common stock     d   performance stock units     a          common stock     d   explanation of responses   options vest on june   and  options vest each three months thereafter starting september    subject to stockholder approval of the companys  omnibus equity incentive plan at the companys annual meeting each performance stock unit represents the right to receive one share of common stock upon vesting of the unit based on achievement of specified targets related to the companys financial performance s erich mohr   signature of reporting person date reminder report on a separate line for each class of securities beneficially owned directly or indirectly  if the form is filed by more than one reporting person see instruction  bv  intentional misstatements or omissions of facts constitute federal criminal violations see  usc  and  usc ffa note file three copies of this form one of which must be manually signed if space is insufficient see instruction  for procedure persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid omb number free breaking news alerts from streetinsidercom email address streetinsidercom top tickers   msft  v  ebay  etfc  ge  athn  swks  cof  uso  skx top news most read special reports wall street dips as ge energy shares weigh microsoft msft tops q eps by c white house spokesman spicer out as trump seeks to fix image general electric ge tops q eps by c revenues beat visa v tops q eps by c sales beat tupperware brands tup windsdown beauticontrol unit after unsuccessful sale jacobs engineering jec is said to be in advanced talks to buy chm  bloomberg citing times baozun bzun pt raised to  at bofamerrill lynch positive fy eps revisions general electric ge tops q eps by c revenues beat afterhours stock movers  aezs athn msft higher manh ncr mxim lower more preopen movers  plug aezs athn higher manh smci ncr lower more afterhours stock movers  aezs athn msft higher manh ncr mxim lower more preopen movers  hpj shld srpt higher ptc chrw fmsa lower more afterhours stock movers  hpj ava srpt higher ptc cfrx chrw lower more preopen stock movers  aezs vrtx sni higher drys ntrs hdp lower more serious news for serious traders try streetinsidercom premium free you may also be interested in shorts ignoring delmar pharma dmpi move so far pratt  whitney canada to bring its  engine celebration to eaa airventure  hexater receives high praise from entrepreneurcom best wordpress themes list create email alert related categories sec filings login with facebook add your comment name subject body share on facebook verification cant see the text click here to refresh the image whats this sign up for streetinsider free receive full access to all new and archived articles unlimited portfolio tracking email alerts custom newswires and rss feeds  and more  free news feedget our rss feed  copyright  streetinsidercom home members home premium content links entities about streetinsider get our content advertise with us contact us disclaimer privacy policy board of directors   company  news   our people   awards  our people management team   scientific advisors   board of directors  board of directors erich mohr phd rpsych chairman  chief executive officer founder of medgenesis therapeutix inc erich mohr phd rpsych is the chairman and ceo of medgenesis therapeutix inc which he founded in  dr mohr a professor of medicine and psychology at the university of ottawa until  has over  years of experience in experimental therapeutics of cns disorders he is credited with over  publications books book chapters and abstracts and has edited the handbook of clinical trials the neurobehavioral approach dr mohr has chaired andor served on several regulatory advisory panels for the approval of new products for the treatment of neurodegenerative disease and is the former chairman and chief executive officer of cromedica global inc which merged with pra international in  to form one of the top  contract research organizations in the world and the cofounder of several biotechnology companies his most recent position was with pra international where he served as chief scientific officer over the course of his career dr mohr has overseen andor participated in dozens of clinical development programs resulting in a number of approved drugs patrick pat k donnelly current chairman  chief executive officer aptiv solutions former president  chief executive officer pra international mr donnelly is the former president  ceo and board member of pra international nasdaq prai having joined the company in  he was instrumental in directing pras dramatic growth from a small regional contract research organization to one of the top global players in the industry with over  million in revenue during his tenure as chief financial officer and chief operating officer then as president and in  as ceo he executed and integrated thirteen strategic international acquisitions as well as lead the company through its ipo in  and subsequent successful secondary offering in  both raising over  million and stock appreciation of  since the ipo in  pra international was named to forbes top  best small companies and in  it was ranked th in businessweeks top  growth companies prior to his tenure at pra he was president of virginia capital lp and vedcorp llc two affiliated venture capital firms he also spent eight years with bancboston capital mr donnelly graduated from the pennsylvania state university with a mba in  and a bs from the university of missouri in  h christian fibiger phdchief scientific officer h christian fibiger phd received his bsc in chemistry and psychology from the university of victoria in  and his phd in psychopharmacology from princeton university in  dr fibiger was formerly the chief scientific officer for biovail laboratories international now valeant from  until  he was vice president and global head of neuroscience at amgen in this position he was responsible for amgen�s worldwide neuroscience discovery efforts ranging from early exploratory research through clinical candidate selection before joining amgen in  dr fibiger served as vice president of neuroscience discovery research and clinical investigation and lrl europe at eli lilly and company before moving to lilly in  dr fibiger served as professor and head of the division of neurological sciences and chair of the university graduate program in neuroscience at the university of british columbia in vancouver he has made numerous contributions to neuroscience research and during his academic career was among the top  most cited scientists in neuroscience he has received many honors for his research contributions including the clark institute prize in psychiatry the heinz lehmann award of the canadian college of neuropsychopharmacology the killam research prize the gold medal in health sciences from the science council of british columbia and the tanenbaum distinguished scientist award in schizophrenia research he is a fellow of the american college of neuropsychopharmacology acnp dr fibiger serves on the editorial boards of several journals in the field of neuroscience and has been coeditor of neuropsychopharmacology the official publication of the american college of neuropsychopharmacology ken newportformer president cromedica global inc ken newport is an entrepreneur and life sciences business executive as a graduate from the university of waterloo and a chartered accountant mr newport had early success in the financial services industry and served as a partner in a chartered accounting firm his focus changed to life sciences in the mid nineties with the formation of cromedica global inc a contract research organization as cofounder and president he witnessed cromedicas growth to  employees within six years by the time that cromedica merged with pra international inc in  cromedica had annual revenues of over  million with  offices in  countries the combined company became one of the  largest contract research organizations in the world with  employees mr newport served as a senior vice president and executive committee member for the last three years until his recent retirement mr newport was also a founding member of global biomedical capital corporation zelos therapeutics inc prime trials inc and other life science organizations he is now a corporate director on several corporate and not for profit boards including his role as chairman of biocanrx     � medgenesis therapeutix inc   delmar pharmaceuticals appoints biopharmaceutical industry veteran erich mohr phd rpsych to delmar pharmaceuticals appoints biopharmaceutical industry veteran erich mohr phd rpsych to the board of directors apr    et from delmar pharmaceuticals inc vancouver british columbia and menlo park calif april   prnewswire  delmar pharmaceuticals inc otcqx dmpi delmar and the company today announced that it has appointed biopharmaceutical industry veteran erich mohr phd rpsych to its board of directors as an independent director dr mohr has close to two decades of biotechnology experience in executive leadership roles as cofounder chief scientific officer chief executive officer and board member including serving as the chairman of a leading canadian contract research organization over the course of his prestigious career dr mohr has overseen and participated in dozens of clinical development programs and regulatory advisory panels we are delighted to have dr mohr join the board stated jeffrey bacha delmars president and ceo his extensive successful background in the research and development of innovative pharmaceutical treatment options and orphan drugs is a perfect fit for delmar dr mohrs guidance will be invaluable as we advance our investigational drug val this year into registration studies for refractory glioblastoma multiforme gbm and prepare to initiate our phase  trials in nonsmall cell lung cancer dr mohr is currently chairman chief executive officer and founder of medgenesis therapeutix inc a privatelyheld biopharmaceutical company committed to developing and commercializing innovative therapeutics to provide lifeenhancing treatments to patients with serious neurologic diseases formerly he was chairman and chief executive officer of cromedica global inc which merged with pra international in  to form one of the major contract research organizations in the world in addition to his industry experience dr mohr has over  years of experience in experimental therapeutics of cns disorders including eight years at the university of ottawa ultimately as a professor of medicine neurology and psychology i am very pleased to join the delmar board at such an exciting time as the company prepares for the highly anticipated start of the registration program for gbm val in gbm is very promising and the management teams commitment to developing a viable treatment option is more than commendable commented dr mohr the strategic expansion into nonsmall cell lung cancer has the potential to showcase the broad utility of val and is a great step forward in building a robust pipeline and unlocking value for shareholders dr mohr is the author of over  publications books book chapters and abstracts currently he is the chair of the board of governors of the university of victoria british columbia having previously served as a member and as vice chair dr mohr is a member of the american society for experimental neurotherapeutics asent the collegium internationale neuropsychopharmacologicum the international psychogeriatric association the canadian psychological association the canadian college of neuropsychopharmacology the movement disorders society the american academy of neurology and the international neuropsychological society he earned his masters of science and phd in neuropsychology at the university of victoria british columbia and his bachelors of arts in psychology and dual bachelors of science in chemistry and biology from the university of the pacific in stockton california about val val is a firstinclass smallmolecule chemotherapeutic in more than  phase  and  clinical studies sponsored by the national cancer institute val demonstrated safety and efficacy in treating a number of cancers including lung brain cervical ovarian tumors and leukemia val is approved in china for the treatment of chronic myelogenous leukemia and lung cancer and has received orphan drug designation in europe and the us for the treatment of gliomas as a potential treatment for glioblastoma vals mechanism of action appears to be unaffected by the expression of mgmt a dna repair enzyme that causes chemotherapy resistance to frontline treatment with temodar® temozolomide delmar is currently studying val in a phase  clinical trial for patients with refractory glioblastoma multiforme about delmar pharmaceuticals inc delmar pharmaceuticals inc was founded to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing or have become intolerable to modern targeted or biologic treatments the companys lead drug in development val is currently undergoing clinical trials in the us as a potential treatment for refractory glioblastoma multiforme val has been extensively studied by us national cancer institute and is currently approved for the treatment of chronic myelogenous leukemia cml and lung cancer in china published preclinical and clinical data suggest that val may be active against a range of tumor types via a novel mechanism of action that could provide improved treatment options for patients for further information please visit wwwdelmarpharmacom or contact jeffrey a bacha president  ceo   or amato  partners llc investor relations at adminamatoandpartnerscom follow us on twitter delmarpharma or on facebook facebookcomdelmarpharma safe harbor statement any statements contained in this press release that do not describe historical facts may constitute forwardlooking statements as that term is defined in the private securities litigation reform act of  any forwardlooking statements contained herein are based on current expectations but are subject to a number of risks and uncertainties the factors that could cause actual future results to differ materially from current expectations include but are not limited to risks and uncertainties relating to the companys ability to develop market and sell products based on its technology the expected benefits and efficacy of the companys products and technology the availability of substantial additional funding for the company to continue its operations and to conduct research and development clinical studies and future product commercialization and the companys business research product development regulatory approval marketing and distribution plans and strategies these and other factors are identified and described in more detail in our filings with the sec including our current reports on form k source delmar pharmaceuticals inc related links httpwwwdelmarpharmacom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more apr    et preview delmar pharmaceuticals announces panel participation in cancer advance boston conference on april   mar    et preview delmar pharmaceuticals to present at the th annual roth conference on march   my news release contains wide tables view fullscreen read more jun    et delmar pharmaceuticals announces completion of first site jun    et delmar pharmaceuticals appoints saiid zarrabian to the board of jun    et delmar pharmaceuticals joins national brain tumor societys looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip background checks and public records search  truthfinder call toll free   public records search social media photos police records background checks contact information and much more start here  try searching a friend relative celebrity yourself or someone else you might know first name last name city state all states alabama alaska arizona arkansas california colorado connecticut district of columbia delaware florida georgia hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota ohio oklahoma oregon pennsylvania rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming this is me searching for yourself search this secure connection is confirmed were very popular what our happy users are saying truthfindercom is freakishly accurate… really scary how much info is out there zac k you found an old friend for me thank you nancy v truthfinder is an excellent site for finding out about someone sherrie f this site is so wonderful i found my lost godchildren and their mom thank you so much lawrence w this is one way to really know a potential date charmaine r your service is more than perfect it is a blessing thank you for the very hard work that you do richard b truthfinder is a very accurate updated system their information is proper and can be very helpful too juan m notice this site contains real police records court records of driving citations speeding tickets felonies misdemeanors sexual offenses mugshots etc background reports photos court documents address information phone numbers and much more please be careful when conducting a search and ensure all the information you enter is accurate learning the truth about the history of your family and friends can be shocking so please be cautious when using this tool truthfinder does not provide consumer reports and is not a consumer reporting agency we provide a lot of sensitive information that can be used to satisfy your curiosity protect your family and find the truth about the people in your life you may not use our service or the information it provides to make decisions about consumer credit employers insurance tenant screening or any other purposes that would require fcra compliance i understand help us refine your results select your gender male female next skip